phelligridimer A
an antioxidant isolated from the fungus Phellinus igniarius; structure in first source
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Chung, Jong-Sang:
1 article
(04/2008)
|
| 2. | Han, Sang-No:
1 article
(04/2008)
|
| 3. | Jung, Ju-Young:
1 article
(04/2008)
|
| 4. | Kang, Il-Jun:
1 article
(04/2008)
|
| 5. | Kang, Young-Hee:
1 article
(04/2008)
|
| 6. | Lee, Yeon Sil:
1 article
(04/2008)
|
| 7. | Lim, Soon Sung:
1 article
(04/2008)
|
| 8. | Shin, Hyun-Kyung:
1 article
(04/2008)
|
| 9. | Li, Shuai:
1 article
(10/2005)
|
| 10. | Mo, Shun-Yan:
1 article
(10/2005)
|
Related Diseases
| 1. | Diabetes Complications
04/01/2008
- " In an effort to characterize active principles for diabetic complication from medicinal mushroom, aldose reductase inhibitors were isolated from the fruiting body of Phellinus linteus and identified as hispidin (5), phelligridimer A (6), davallialactone (7), methyldavallialactone (8), hypholomine B (9), interfungins A (10), and inoscavin A (11), together with protocatechuic acid (1), protocatechualdehyde (2), caffeic acid (3), and ellagic acid (4). "
|
| 2. | Neoplasms (Cancer)
|
|
Related Drugs and Biologics